Aceragen Announces Acquisition of Arrevus, Expands Late-Stage Rare Disease Pipeline
November 01, 2021 10:13 ET
|
Aceragen
RALEIGH-DURHAM, N.C , Nov. 01, 2021 (GLOBE NEWSWIRE) -- Aceragen, Inc., a biopharmaceutical company focused on advancing transformational therapeutics for rare and orphan diseases, today announced...